🎗️ Pharmidex Supports World Cancer Day 🎗️
February 4, 2025
Today, on
World Cancer Day, we stand in solidarity with the global fight against cancer.
At
Pharmidex, we are committed to advancing preclinical solutions that drive innovation in cancer research. Through our expertise in drug discovery and strong collaborations with partners, we strive to accelerate the development of life-saving therapies.
🔬 Together, we can make a difference. By combining knowledge, technology, and dedication, we move closer to finding a cure. Let’s continue working hand in hand towards a cancer-free future.
💜 Join the movement:
https://lnkd.in/emGk7DU
#Pharmidex #WorldCancerDay #CancerResearch #DrugDiscovery #Collaboration #Innovation #TogetherWeCan
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
